Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Nanomedicine: HELP
Fabian Kiessling
Based on 36 articles published since 2010
(Why 36 articles?)
||||
Expertise Level
The expertise of Fabian Kiessling ranks in the
  • Top 0.017%
  • ... of 28,678 published authors worldwide on Nanomedicine
  • ... from 2010 through 2020
  • ... based on contributions to 36 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kiessling, F   ·   Kiessling, Fabian
Work Locations
Details
Most likely:    RWTH Aachen      
2019
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Institute of Pathology, Medical Faculty, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Nuclear Medicine, RWTH Aachen University Clinic, Aachen, Germany; Leibniz Institute for Interactive Materials - DWI, RWTH Aachen University, Aachen, Germany. · Institute of Pathology, Medical Faculty, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 30639256
  • Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Medicine III, University Hospital Aachen, Aachen, Germany; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands. · Department of Medicine III, University Hospital Aachen, Aachen, Germany; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany. Electronic address: · Pubmed 30925288
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Nuclear Medicine, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht University, Utrecht, the Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede, the Netherlands. Electronic address: · Pubmed 30009886
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Institute of Inorganic Chemistry, University of Cologne, Cologne, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany. · Pubmed 28205399
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • a Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging , University Clinic and Helmholtz Institute for Biomedical Engineering , Aachen , Germany. · c Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS) , Utrecht University , Utrecht , The Netherlands. · b Department of Targeted Therapeutics, Enschede MIRA Institute for Biomedical Technology and Technical Medicine , University of Twente , Enschede , The Netherlands. · Pubmed 27461854
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Immunology and Oncology and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB)/CSIC, Darwin 3, Cantoblanco, 28049 Madrid, Spain. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Cristal Therapeutics, Oxfordlaan 55, 6229 EV Maastricht, the Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Controlled Drug Delivery, University of Twente and MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, The Netherlands. · Pubmed 25893004
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • 1. Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; · 2. Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany; · 2. Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany; ; 3. Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany. · 1. Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; ; 4. Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands ; 5. Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · 6. LuFG Informatik 12, RWTH Aachen University, Aachen, Germany. · Pubmed 25157277
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany ; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands ; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24860796
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2019
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Pubmed 30465669
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
2012
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Pubmed 22829203
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21907796
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2010
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21143030
Possible:    Universiteit Utrecht      
2015
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 25929568
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 36 total) written by Fabian Kiessling about Nanomedicine:

  • Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. 2019
  • Nanomedicine and macroscale materials in immuno-oncology. 2019
  • Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. 2019
  • Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation. 2018
  • Tumor targeting via EPR: Strategies to enhance patient responses. 2018
  • Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors. 2018
  • Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. 2017
  • Enhancing Tumor Penetration of Nanomedicines. 2017
  • Status and trends in the development of clinical diagnostic agents. 2017
  • Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers. 2017
Show List of Full Article Records
Google Searches

Learn more about Fabian Kiessling using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
RWTH Aachen
Universiteit Utrecht
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
RWTH Aachen
2019
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Institute of Pathology, Medical Faculty, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Nuclear Medicine, RWTH Aachen University Clinic, Aachen, Germany; Leibniz Institute for Interactive Materials - DWI, RWTH Aachen University, Aachen, Germany. · Institute of Pathology, Medical Faculty, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 30639256
  • Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Medicine III, University Hospital Aachen, Aachen, Germany; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands. · Department of Medicine III, University Hospital Aachen, Aachen, Germany; Department of Hepatology and Gastroenterology, Charité University Medicine Berlin, Berlin, Germany. Electronic address: · Pubmed 30925288
2018
  • a Department of Physics , Norwegian University of Science and Technology (NTNU) , Trondheim , Norway. · b Department of Biotechnology and Nanomedicine , SINTEF AS , Trondheim , Norway. · c Cancer Clinic , St. Olavs Hospital , Trondheim , Norway. · d Imaging Division , University Medical Center , Utrecht , The Netherlands. · e Department of Pharmaceutics , Utrecht University , Utrecht , The Netherlands. · f Department of Targeted Therapeutics , University of Twente , Enschede , The Netherlands. · g Institute for Experimental Molecular Imaging , RWTH Aachen University , Aachen , Germany. · Pubmed 30415585
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Nuclear Medicine, RWTH Aachen University Clinic, Aachen, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany; Department of Pharmaceutics, Utrecht University, Utrecht, the Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede, the Netherlands. Electronic address: · Pubmed 30009886
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Institute of Macromolecular Chemistry, Czech Academy of Science, Prague, Czech Republic. · Max Planck Institute for Polymer Research, Mainz, Germany. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Biointerface Laboratory, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany. · Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic and Helmholtz Institute for Biomedical Engineering, Aachen, Germany; Department of Targeted Therapeutics, Biomaterial Science and Technology, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: · Pubmed 29730154
2017
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands. · Imaging division, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany. Electronic address: · Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Clinic, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CG, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, 7500 AE Enschede, The Netherlands. Electronic address: · Pubmed 28697952
  • Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic , 52074 Aachen, Germany. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Utrecht, 3584 CG, The Netherlands. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , Enschede, 7522 NB, The Netherlands. · Pubmed 28328191
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands. · Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. · Pubmed 27800665
  • Institute of Chemistry & Biology of Membranes & Nanoobjects (CBMN), UMR 5248, University of Bordeaux, Pessac, France. · Institute for Experimental Molecular Imaging, RWTH Aachen University Clinic, Aachen, Germany. · Fujifilm VisualSonics BV, Amsterdam, the Netherlands. · Pubmed 28572726
  • Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Intensive Care, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany. · Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Genetics and Cell Biology - Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands. · Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. · DWI-Leibniz Institute for Interactive Materials, RWTH Aachen University, Forckenbeckstr. 50, 52056 Aachen, Germany. · Department of Experimental Molecular Imaging (ExMI), Helmholtz Institute for Biomedical Engineering, University Hospital RWTH, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Targeted Therapeutics, Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3583 CG Utrecht, The Netherlands. Electronic address: · Pubmed 28279799
  • Institute of Inorganic Chemistry, University of Cologne, Cologne, Germany. · Department of Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany. · Pubmed 28205399
  • Department of Medicine III, University Hospital Aachen, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Medicine III, University Hospital Hamburg-Eppendorf, Hamburg, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czechia. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Institute of Organic Chemistry, Johannes Gutenberg University, Mainz, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Department of Medicine III, University Hospital Aachen, Aachen, Germany. Electronic address: · Pubmed 27855336
2016
  • a Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging , University Clinic and Helmholtz Institute for Biomedical Engineering , Aachen , Germany. · c Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS) , Utrecht University , Utrecht , The Netherlands. · b Department of Targeted Therapeutics, Enschede MIRA Institute for Biomedical Technology and Technical Medicine , University of Twente , Enschede , The Netherlands. · Pubmed 27461854
  • Institute of Chemistry & Biology of Membranes & Nano-objects, CBMN UMR 5248, Bordeaux University , 33600 Pessac, France. · Experimental Molecular Imaging, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Gastroenterology and Metabolic Disorders, RWTH Aachen University Clinic , 52056 Aachen, Germany. · Pubmed 27412680
  • Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Cristal Therapeutics, Oxfordlaan 55, Maastricht 6229EV, The Netherlands. · Institute of Macromolecular Chemistry, the Czech Academy of Sciences, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. · Department of Biomaterials Science and Technology, Section: Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584CG, The Netherlands. Electronic address: · Pubmed 27401327
2015
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen, Germany. · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente , P.O. Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 26166537
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Pubmed 25969868
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. · Department of Immunology and Oncology and NanoBiomedicine Initiative, Centro Nacional de Biotecnología (CNB)/CSIC, Darwin 3, Cantoblanco, 28049 Madrid, Spain. · Institute of Organic Chemistry, Johannes Gutenberg-University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany. · Cristal Therapeutics, Oxfordlaan 55, 6229 EV Maastricht, the Netherlands. · Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. · Department of Controlled Drug Delivery, University of Twente and MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, The Netherlands. · Pubmed 25893004
2014
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. Electronic address: · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Controlled Dug Delivery, MIRA Institute for Biomedical Engineering and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24316070
  • 1. Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; · 2. Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany; · 2. Department of Experimental Medicine and Immunotherapy, Institute of Applied Medical Engineering, University Hospital RWTH Aachen, Aachen, Germany; ; 3. Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology, Aachen, Germany. · 1. Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany; ; 4. Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands ; 5. Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · 6. LuFG Informatik 12, RWTH Aachen University, Aachen, Germany. · Pubmed 25157277
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany ; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands ; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Pubmed 24860796
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany. · Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic. · Imaging Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Aachen, Germany; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. Electronic address: · Pubmed 24631862
  • Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, (The Netherlands). · Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, (USA). · Cristal Delivery B.V. Oxfordlaan 55, 6229 EV Maastricht, (The Netherlands). · Department of Targeted Therapeutics, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede (The Netherlands). · Institute of Macromolecular Chemistry AS CR, v.v.i., Heyrovského nám. 2, 162 06 Prague 6, (Czech Republic). · Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen (Germany). · Omaha VA Medical Center, 4101 Woolworth Avenue, Omaha, (USA). · Department Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE 68198, (USA). · Pubmed 24341611
2013
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Cytometry Lab, Department of Molecular Biophysics, University of Lodz, Banacha Street 12/16, 90-237 Lodz, Poland. · Department of Controlled Drug Delivery, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, PO Box 217, 7500 AE, Enschede, The Netherlands. · Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 24120954
2019
  • Department of Nanomedicines and Theranostics, Institute for Experimental Molecular Imaging, Uniklinik RWTH Aachen and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, 52074 Aachen, Germany. · Pubmed 30465669
2015
  • RWTH Aachen University, University Clinic and Helmholtz Institute for Biomedical Engineering, Institute for Experimental Molecular Imaging (ExMI), Department of Nanomedicines and Theranostics , Pauwelsstrasse 30, 52074 Aachen , Germany. · Pubmed 26083469
2013
  • Department of Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH - Aachen University, Aachen, Germany. · Pubmed 23578464
2012
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen, Germany. · Pubmed 22829203
  • Department of Experimental Molecular Imaging, RWTH - Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 22214503
  • Department of Pharmaceutical Sciences, Mahatma Gandhi University, Cheruvandoor campus, Ettumanoor, Kerala, India. · Pubmed 21631585
  • Department of Experimental Molecular Imaging, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21907796
2011
  • Department of Experimental Molecular Imaging, Helmholtz Institute for Biomedical Engineering, RWTH-Aachen University, Pauwelsstrasse 20, 52074 Aachen, Germany. · Pubmed 21545096
2010
  • Department of Experimental Molecular Imaging, RWTH-Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany. · Pubmed 21143030
Universiteit Utrecht
2015
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 25929568
2011
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands. · Pubmed 21901211
2010
  • Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands. · Pubmed 20822168
Yearly article counts 03373552422
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.